SEC Form 4 · accession 0001615774-18-006001
ATOSSA GENETICS INC · ATOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kyle Guse
Officer — CFO, Gen Counsel and Secretary
Period of report
Jun 27, 2018
Accepted (ET)
Jun 29, 2018 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488039
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.38 | Jun 27, 2018 | A | 700,000 | A | — | Jun 27, 2028 | Common Stock | 700,000 | 700,000 | D |
Explanation of responses
- F1Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones.